Vaccinex, inc. (VCNX)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-7,149

-6,326

-7,642

-8,828

-9,067

-8,449

-6,599

-6,608

-7,862

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

-

-

-

-

-

-

54

56

56

Depreciation

75

-

-

-

60

-

-

-

-

Amortization of debt discount

-

-

-

-

-

0

24

49

235

Net amortization of premiums and discounts on marketable securities

-

0

-1

3

42

-

-

-

-

Stock-based compensation

204

138

136

113

60

46

43

52

36

Change in fair value of derivative liabilities

-

-

-

-

-

0

31

30

308

Loss on extinguishment of related party convertible promissory note

-

-

-

-

-

0

-199

0

-2,180

Changes in operating assets and liabilities:
Accounts receivable

-130

-189

217

243

-11

236

51

272

-37

Prepaid expenses and other current assets

380

-307

227

-416

-229

-494

718

95

65

Accounts payable

-3

704

-3,105

3,009

117

98

-691

666

348

Accrued expenses

-387

-883

500

-467

156

546

641

911

309

Deferred revenue

-

-

-

-

-

-42

-62

-63

-131

Net cash used in operating activities

-7,510

-5,803

-10,490

-5,946

-8,476

-7,557

-7,220

-5,334

-5,165

CASH FLOWS FROM INVESTING ACTIVITIES:
Sales of marketable securities

-

1

0

2,350

11,800

-

-

-

-

Purchase of property and equipment

254

-

-

-

-

169

5

14

47

Net cash (used in) provided by investing activities

-254

0

-10

2,283

11,800

1,917

-16,097

-14

-47

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from private offering of common stock

7,475

-

-

-

-

-

-

-

-

Payments of initial public offering costs

-

-

-

-

-

0

2,348

283

44

Proceeds from exercise of stock options

4

-

-

-

-

-

-

-

-

Repayment of convertible promissory note, related party

-

-

-

-

-

0

1,500

0

4,000

Proceeds from capital contribution

-

-

-

-

-

0

0

4,000

8,000

Net cash provided by financing activities

7,479

-

-

-

-

0

33,277

3,722

3,956

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

-285

-

-

-

3,324

-

-

-

-

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for interest

-

-

-

-

-

-

-

-

13

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

-

-

-

-

-

-

-

-1,626

-1,256

SUPPLEMENTAL DISCLOSURES OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Purchase of property and equipment in accounts payable

161

-

-

-

-

-

-

-

9

Deferred offering costs in prepaid assets and accrued liabilities

40

-

-

-

-

-

-

-

-

Deferred offering costs in prepaid assets and accounts payable

253

-

-

-

-

-

-

787

573

Deferred offering costs reclassed from prepaid expenses and other current assets

-

-

-

-

-

-

-

-

38